Archean Chemical promoter pledges 30,000 shares for loan collateral

scanx
Reviewed by
Anirudha BScanX News Team
Key Highlights
  • Chemikas Speciality LLP pledged 30,000 shares of Archean Chemical Industries
  • Encumbrance created on September 1, 2026, as loan collateral
  • Pledge represents 0.024% of total share capital
  • Total encumbered holding rises to 11.32% of capital
powered bylight_fuzz_icon
50507640

*this image is generated using AI for illustrative purposes only.

Archean Chemical Industries promoter Chemikas Speciality LLP created a pledge on 30,000 equity shares on September 1, 2026. The encumbrance was registered in favour of Piramal Trusteeship Services Private Limited to serve as collateral for loans.

The disclosure was made pursuant to Regulation 31 of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The pledged shares represent 0.024% of the company’s total share capital.

Pledge Details

Metric Value
Promoter Entity Chemikas Speciality LLP
Shares Pledged 30,000
Date of Creation September 1, 2026
Purpose Collateral for loans
Beneficiary Piramal Trusteeship Services Private Limited
% of Total Capital 0.024%

Post-Event Holding

Following the creation of the pledge, Chemikas Speciality LLP’s total encumbered holding stands at 1,39,80,010 shares. This accounts for 11.32% of Archean Chemical Industries’ total share capital.

The promoter group’s total holding in the target company remains at 3,76,93,219 shares, constituting 30.53% of the total share capital. Co-promoter P Ranjit holds 2,82,65,965 shares (22.90%), which remain unencumbered.

Historical Stock Returns for Archean Chemical Industries

1 Day5 Days1 Month6 Months1 Year5 Years
-0.15%-2.74%-5.15%-9.54%-30.17%0.0%

How might the increase in Chemikas Speciality LLP's encumbered holding to 11.32% impact investor confidence and the stock's liquidity?

What specific financial obligations or expansion plans is Archean Chemical Industries likely funding through this collateralized loan?

Could this pledge signal broader promoter-level liquidity pressures, and are there indications of further share pledges in the near term?

Archean Chemical Industries
View Company Insights
View All News
like15
dislike

SBI Mutual Fund reduces Archean Chemical stake to 4.34% via market sale

scanx
Reviewed by
Anirudha BScanX News Team
Key Highlights
  • SBI Mutual Fund sold 1,47,599 shares of Archean Chemical Industries
  • Stake reduced from 4.4640% to 4.3444% of paid-up capital
  • Transaction executed via open market sale on September 3, 2026
  • Final holding stands at 53,63,574 shares as per regulatory filing
powered bylight_fuzz_icon
50133808

*this image is generated using AI for illustrative purposes only.

SBI Mutual Fund reduced its stake in Archean Chemical Industries to 4.34% following a market sale of 1,47,599 shares on September 3, 2026.

The mutual fund reported the change in shareholding under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The disclosure was filed on September 4, 2026.

Transaction Details

Prior to the sale, SBI Mutual Fund held 55,11,173 shares, representing 4.4640% of the company’s paid-up equity capital. The disposal of 1,47,599 shares, equivalent to 0.1196% of the total share capital, brought the final holding down to 53,63,574 shares.

The transaction was executed through an open market sale. There were no changes in voting rights other than those carried by the shares, nor any encumbrances or convertible securities involved in the transaction.

Shareholding Structure

Metric Before Sale After Sale
Shares Held 55,11,173 53,63,574
Stake Percentage 4.4640% 4.3444%
Shares Sold N.A. 1,47,599

Archean Chemical Industries has a total paid-up equity capital of ₹24,69,16,788, consisting of 12,34,58,394 equity shares with a face value of ₹2 each. This capital structure remained unchanged following the transaction.

Historical Stock Returns for Archean Chemical Industries

1 Day5 Days1 Month6 Months1 Year5 Years
-0.15%-2.74%-5.15%-9.54%-30.17%0.0%

Will SBI Mutual Fund continue to reduce its exposure to Archean Chemical Industries in upcoming quarters, or was this sale a one-time portfolio rebalancing?

How might this institutional exit impact Archean Chemical Industries' stock price volatility and liquidity in the near term?

Are there other major institutional investors currently adjusting their stakes in Archean Chemical Industries, signaling a broader shift in market sentiment?

Archean Chemical Industries
View Company Insights
View All News
like15
dislike

More News on Archean Chemical Industries

1 Year Returns:-30.17%